glp 1 neurodegenerative disease Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's Repurposing glucagon-like peptide-1 receptor agonists
Pay in 4 interest-free payments of $6.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26



























